Oncology Insights

Want to explore more topics around the cancer care pathway? Learn about upcoming events and go deeper with thought leadership pieces, case studies and research.

Thought Leadership & Research

General
Early Detection
Diagnosis
Treatment
Follow-Up

White Paper

The next chapter of cancer care will require new approaches, tools, and technologies

Article

Improving Global Health Equity to Reduce the World Cancer Burden

Video

Tiny Signs of Hope: Advancing Theranostics, Ep. 5 – Hope for Many

Video

Tiny Signs of Hope: Advancing Theranostics, Ep. 2-A Vision for Hope

Case Study

Best practices for implementing ABUS

Article

The Future of Prostate Cancer Diagnosis Could Involve Fewer Biopsies

Article

How AIR Coils and AIR Recon DL Are Revolutionizing Prostate Imaging

Article

Breathing Easier: How AI is Aiding in Identifying the World’s Deadliest Cancer

Article

Theranostics: Progressing Precision Medicine and Cancer Care as a Vision for Hope

White Paper

TrueFidelity DL’s Impact on CT Image Quality, Diagnostic Performance and Radiation Dose Optimization

Article

Making Theranostics a Reality in Clinical Practice

Article

Fortifying the Pathway to Hope with Theranostics

Article

A promising outlook across the prostate cancer care pathway

Article

Next chapter: cancer care with new tools and technologies

Article

Progressive leadership in men’s health: transforming prostate care and beyond

Footnotes

1. Gordon PB. The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening. Curr Oncol. 2022;29(5):3595-3636. Published 2022 May 17. doi:10.3390/curroncol29050291. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140155/
2. FDA PMA P110006 summary of safety and effectiveness. https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110006B.pdf
4. Henschke CI, et al., A 20-year follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Radiology 2023; DOI: 10.1148/radiol.231988.
5. Selove R, Kilbourne B, Fadden MK, et al. Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization. Women’s Health Issues. 2016;26(6):642-647. doi:10.1016/j.whi.2016.09.003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116399
6. Chang SB, et al. SS2-06. Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment. Presented at: San Antonio Breast Cancer Symposium, 2020. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1186409
7. Based on a simulated user evaluation of OncoFlow at a UK University hospital in a test environment with 15 external users familiar with cancer patient medical records (7 oncologist, 5 nurses, 2 practitioners, 1 MDT coordinator). Each participant completed a series of tasks using both their existing EMR system and OncoCare. Mouse clicks and time to perform each task were recorded. User experience feedback was collected with a survey questionnaire. The study was facilitated by a third-party consulting agency and sponsored by GE HealthCare. The results are not prescriptive and could vary depending on user, electronic patient medical records software used, and circumstances.
8. Global Oncology Trends 2019, IQVIA Institute, ©2019 IQVIA, May 2019. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-oncology-trends-2019
9. MEDraysintell 2021; Marketed Radiopharmaceuticals Report & Directory – Edition 2021.
10. Schenkel C, Levit LA, Kirkwood MK, et al. The state of professional wellbeing and satisfaction among US oncologists. Presented at ASCO Quality Care Symposium 2023. October 27-28, 2023. Boston, Massachusetts. Abstract. https://meetings.asco.org/abstracts-presentations/228098

* Revolution™ is a trademark of GE HealthCare, One-Stop Clinic™ is a trademark of GE HealthCare
** **Optellum Virtual Nodule Clinic is a third-party application distributed by GE HealthCare. Optellum Virtual Nodule Clinic software has been trained using multiple databases of CT scans and eventual diagnoses from healthcare systems in the UK, US, and Europe.